CYP4 Isoform Specificity in the ω-Hydroxylation of Phytanic Acid, a Potential Route to Elimination of the Causative Agent of Refsum’s Disease
Phytanic acid
Phytol
Hydroxylation
DOI:
10.1124/jpet.106.104976
Publication Date:
2006-05-18T00:44:10Z
AUTHORS (4)
ABSTRACT
The saturated C20 isoprenoid phytanic acid is physiologically derived from phytol released in the degradation of chlorophyll. presence a C-3 methyl group this substrate blocks normal β-oxidation, so primarily occurs by initial peroxisomal α-oxidation to shift register group. However, individuals with Refsum9s disease are genetically deficient required phytanoyl-CoA α-hydroxylase and suffer neurological pathologies caused accumulation acid. Recent work has shown that can also be catabolized pathway initiated ω-hydroxylation hydrocarbon chain, followed oxidation alcohol conventional β-oxidation. enzymes responsible for have not been identified. In study, we determined activities all rat human CYP4A two CYP4F enzymes, respect Furthermore, ability ω-hydroxylate elevated microsomes rats pretreated clofibrate. results support possible role CYP4 enzyme elevation elimination patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (13)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....